Sarawak steps into global biomedical arena with launch of research society

Dr Samuel Ting Chuo Yew
KUCHING (June 14): The Sarawak Society for Cell and Gene Therapy Research (SSCTR) has been officially launched, marking a significant step forward in positioning Sarawak as a contributor to the global biomedical innovation landscape.
Founded by Dr Samuel Ting Chuo Yew, a leading figure in pharmaceutical science and health policy, the SSCTR aims to promote awareness, foster collaboration, and support policy development in the rapidly evolving field of cell and gene therapy (CGT).
'Cell and gene therapy is revolutionizing modern medicine, from offering cures for previously untreatable genetic disorders to enabling personalized regenerative therapies,' said Dr Ting in a statement.
'Yet, in East Malaysia, access to reliable information, local expertise, and institutional coordination in CGT remains limited. SSCTR was created to change that,' he added.
The society is guided by a multidisciplinary council comprising pharmacists, clinicians, biotechnologists, educators, and bioprocessing engineers – reflecting the collaborative nature required to advance CGT from research to clinical application.
'Its success relies on coordinated efforts across basic science, clinical practice, manufacturing, regulation, and public engagement.
'That is why our society was founded with an interdisciplinary vision from day one,' he said.
For researchers and healthcare professionals, the SSCTR provides access to the latest developments in CGT, including technological advancements and regulatory frameworks.
It also facilitates national and international collaborations with key organisations such as the International Society for Cell and Gene Therapy (ISCT), the American Society of Gene and Cell Therapy (ASGCT), and the Malaysia Association for Cell and Gene Therapy (MACGT).
The society also promotes interdisciplinary teamwork among molecular scientists, immunologists, stem cell researchers, GMP specialists, clinical trialists, pharmacists, nurses, and regulatory experts.
For the general public, SSCTR aims to raise awareness about both the potential and limitations of CGT.
It also serves as a trusted point of reference for verifying the credibility of CGT-related services and companies.
For government agencies and policymakers, the society offers expert insights to support the development of national and state-level regulations.
It also acts as an intermediary, facilitating communication and advocacy between public authorities, the healthcare sector, and the wider community.
Membership is now open to researchers, clinicians, students, and members of the public who are committed to the ethical and evidence-based advancement of cell and gene therapy.
To learn more or to join the SSCTR, go to the website https://www.sarawaksctr.com.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Rakyat Post

a day ago

• Rakyat Post

Malaysia Records First COVID-19 Death In 2025

Subscribe to our FREE Malaysia has recorded its first COVID-19-related death of 2025, according to a statement released by the Ministry of Health (MoH) on 19 June. The fatality occurred during Epidemiological Week 24 (8–15 June). The individual, who had serious pre-existing health conditions such as heart disease and diabetes, had not received the second booster dose of the COVID-19 vaccine. MoH noted that this was the first COVID-19 death since 26 May 2024, and a significant drop compared to the 57 COVID-related deaths reported in 2024. COVID-19 Cases on the Rise, But Situation Under Control As of Week 24, Malaysia has reported 21,738 cumulative COVID-19 cases in 2025, with the weekly average hovering around 900 cases. However, MoH did flag a 68% week-on-week spike, with 3,379 cases reported in Week 24 compared to 2,011 the previous week. Despite the increase, the ministry assured that the national COVID-19 situation remains stable and below the national alert threshold. In terms of severe cases, six patients were admitted to the ICU, all with underlying health issues. All have since been discharged from intensive care; four have returned home, while two remain in regular hospital wards for follow-up treatment. New Variant on the Radar: NB.1.8.1 or 'Nimbus' The World Health Organisation (WHO) is closely monitoring the spread of NB.1.8.1, a Photo: Freepik WHO has classified Nimbus as a Variant Under Monitoring (VUM) due to its rapid transmission and potential health risks. Nimbus spreads faster than previous variants. Common symptoms include: razor-blade-like sore throat, fatigue, mild cough, fever, muscle aches and nasal congestion. What You Can Do Health experts continue to urge the public to take precautions, especially as new variants emerge. Wear a high-quality mask in crowded indoor spaces, improve indoor ventilation: open windows, use fans or air purifiers, get tested if you're feeling unwell or exposed to COVID-19, and stay home when sick to reduce the risk of transmission. Photo: Malay Mail While Malaysia's current COVID-19 situation remains under control, this latest death and the emergence of new variants serve as reminders that vigilance and public health measures remain crucial. Share your thoughts with us via TRP's . Get more stories like this to your inbox by signing up for our newsletter.

Sinar Daily

2 days ago

• Sinar Daily

Malaysia reports first Covid-19 death in 2025

Covid-19 cases rose to 3,379 during ME24, up from 2,011 cases the previous week. 20 Jun 2025 08:35am The Health Ministry urges continued vigilance and adherence to vaccination schedules to keep the situation under control. - Bernama file photo PUTRAJAYA - Malaysia recorded its first Covid-19-related death of the year during Epidemiological Week 24 (ME24), according to the Health Ministry (MOH). The fatality involved a patient with serious comorbidities, including heart disease and diabetes, who had not received a second booster dose. The Health Ministry urges continued vigilance and adherence to vaccination schedules to keep the situation under control. - 123RF photo "This marks a significant decline compared to 57 Covid-19 deaths reported in 2024, with the last fatality recorded on May 26 last year,' it said in a statement yesterday. The decline, it added, reflects the effectiveness of ongoing control measures. However, Covid-19 cases rose to 3,379 during ME24, up from 2,011 cases the previous week. Despite the increase, the national situation remains under control and below the alert threshold, due to ongoing surveillance and public health interventions. To date, a total of 21,738 cases have been reported this year, with the weekly average holding steady at around 900. Six patients were admitted to intensive care during ME24, all with underlying health conditions such as hypertension, diabetes, heart disease and Down syndrome. All received intensive care, with four discharged home and two transferred to general wards. MOH continues to encourage all Malaysians, from unborn babies to the elderly, to stay protected by following appropriate vaccination schedules under the National Immunisation Programme. - BERNAMA

Malaysiakini

2 days ago

• Malaysiakini

Malaysia reports its first Covid-19 death in 2025

Malaysia recorded its first Covid-19-related death of the year during Epidemiological Week 24 (ME24), according to the Health Ministry. The fatality involved a patient with serious comorbidities, including heart disease and diabetes, who had not received a second booster dose.